Xerostomia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 On 25thNovember 2014
Summary The industry analysis specialist, has released its new report, “Xerostomia Therapeutics Pipeline Assessment and Market Forecasts to 2019�. The report is an essential source of information and analysis on the global Xerostomia Therapeutics market. The report identifies the key trends shaping and driving the global Xerostomia Therapeutics market. The report also provides insights on the prevalent competitive landscape and the emerging players expected to significantly alter the market positioning of the current market leaders. Most importantly, the report provides valuable insights on the pipeline products within the global Xerostomia Therapeutics sector. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by Our team of industry experts.
You can buy this Report @ http://www.jsbmarketresearch.com/healthcaremedical/r-xerostomia-therapeutics-pipeline-assessment-and-market-forecasts135246 Scope The report provides information on the key drivers and challenges of the Xerostomia Therapeutics market. Its scope includes Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
- Annualized seven key markets (US, France, Germany, Italy, Spain, UK and Japan) Xerostomia Therapeutics market revenues data from 2006 to 2011, forecast for eight years to 2019. - Pipeline analysis data providing a split across the different phases, mechanisms of action being developed and emerging trends by seven key markets. Pipeline candidates fall under major therapeutic classes. - Analysis of the current and future competition in the seven key countries Xerostomia Therapeutics market. - Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications. - Key topics covered include strategic competitor assessment, market characterization, unmet needs and the implications for the Xerostomia Therapeutics market. - Analysis of key recent licensing and partnership agreements in Xerostomia Therapeutics market
Reasons to buy The report will enhance your decision making capability. It will allow you to - Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies and by identifying the companies with the most robust pipeline. - Develop business strategies by understanding the trends shaping and driving the global Xerostomia Therapeutics market. - Drive revenues by understanding the key trends, innovative products and technologies, market segments and companies likely to impact the global Xerostomia Therapeutics market in future. - Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors. - Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage. - Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships. - What’s the next big thing in the global Xerostomia Therapeutics market landscape? – Identify, understand and capitalize. Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Other industries we cover: • • • • • • • • •
Advertising and Media Automotive and Parts Consumer Goods Healthcare and Medical Finance and Banking Food and Beverages Travel and Tourism Textiles and Clothing SWOT Analysis
Discounts on Market Research Reports till 31st December, 2014 For more inquiries, contact at +91 - 998 729 5242 / contact@jsbmarketresearch.com Table of Content 2 Xerostomia Therapeutics - Introduction 2.1 Disease Overview 2.2 Etiology and Pathogenesis 2.2.1 Complications of Xerostomia 2.3 Signs and Symptoms 2.4 Epidemiology 2.5 Socio-economic Status and Quality of Life 2.6 Diagnosis 2.7 Treatment and Management Pattern 2.8 Treatment Algorithm 2.9 Referral Pathway 2.10 GlobalData Pipeline Report Guidance 3 Xerostomia Therapeutics - Market Characterization 3.1 Xerostomia Therapeutics Market Size (2006 - 2011) - Global 3.2 Xerostomia Therapeutics Market Forecast (2011 - 2019) - Global 3.3 Xerostomia Therapeutics Market Size (2006 - 2011) - The US 3.4 Xerostomia Therapeutics Market Forecast (2011 - 2019) - The US 3.5 Xerostomia Therapeutics Market Size (2006 - 2011) - The UK Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
3.6 Xerostomia Therapeutics Market Forecast (2011 - 2019) - The UK 3.7 Xerostomia Therapeutics Market Size (2006 - 2011) - France 3.8 Xerostomia Therapeutics Market Forecast (2011 - 2019) - France 3.9 Xerostomia Therapeutics Market Size (2006 - 2011) - Germany 3.10 Xerostomia Therapeutics Market Forecast (2011 - 2019) - Germany 3.11 Xerostomia Therapeutics Market Size (2006 - 2011) - Italy 3.12 Xerostomia Therapeutics Market Forecast (2011 - 2019) - Italy 3.13 Xerostomia Therapeutics Market Size (2006 - 2011) - Spain 3.14 Xerostomia Therapeutics Market Forecast (2011 - 2019) - Spain 3.15 Xerostomia Therapeutics Market Size (2006 - 2011) - Japan 3.16 Xerostomia Therapeutics Market Size (2011 - 2019) - Japan 3.17 Drivers and Barriers for the Xerostomia Therapeutics Market 3.17.1 Drivers for the Xerostomia Therapeutics Market 3.17.2 Barriers for the Xerostomia Therapeutics Market 3.18 Opportunity and Unmet Need Analysis 3.19 Key Takeaway 4 XerostomiaTherapeutics - Competitive Assessment 4.1 Overview 4.2 Strategic Competitor Assessment 4.3 Product Profiles for the Major Marketed Products in the Xerostomia Therapeutics Market 4.3.1 Evoxac (cevimeline) 4.3.2 Ethyol (amifostine) 4.3.3 Pilocarpine Hydrochloride 4.4 Key Takeaway 5 Xerostomia Therapeutics Market - Pipeline Assessment 5.1 Overview 5.2 Strategic Pipeline Assessment 5.3 Xerostomia Therapeutics Pipeline - Pipeline by Phases of Development 5.3.1 Xerostomia Therapeutics - Phase II Pipeline 5.3.2 Technology Trends Analytic Framework 5.4 Xerostomia Therapeutics Market - Pipeline by Mechanism of Action 5.5 Molecules Profiles for Pipeline Drugs Under Development 5.5.1 P-552-02 5.5.2 APD515 5.5.3 Pilobuc 5.6 Key Takeaway 6 Xerostomia Therapeutics - Clinical Trials Mapping 6.1 Clinical Trials by Region/Country (US, EU5 and Japan) 6.2 Clinical Trials by Phase Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
6.3 Clinical Trials by Trial Status 6.4 Clinical Trials by Sponsors 6.5 Top Companies Participating in Xerostomia Therapeutics Clinical Trials 7 XerostomiaTherapeutics - Strategic Assessment 7.1 Key Events Impacting the Future Market 7.2 Xerostomia Therapeutics - Implications for Future Market Competition 8 Xerostomia Disease Therapeutics - Future Players 8.1 Introduction 8.2 Parion Sciences 8.2.1 Company Overview 8.2.2 Sjogren’s Syndrome (Associated with Xerostomia) Therapeutics Pipeline 8.3 Acacia Pharma 8.3.1 Company Overview 8.3.2 Xerostomia Therapeutics Pipeline 8.4 Marillion Pharmaceuticals 8.4.1 Company Overview 8.4.2 Xerostomia Therapeutics Pipeline 9 Xerostomia Therapeutics - Licensing and Partnership Deals 10 XerostomiaTherapeutics - Appendix 10.1 Market Definitions 10.2 Abbreviations 10.3 Research Methodology 10.3.1 Coverage 10.3.2 Secondary Research 10.3.3 Forecasting 10.3.4 Primary Research 10.3.5 Expert Panel Validation 10.4 Contact Us 10.5 Disclaimer 10.6 Bibliography
List Of Tables Table 1: Extra-oral Signs Frequently Observed in Connection with Xerostomia and Salivary Gland Hypofunction Table 2: Prevalence of Xerostomia Table 3: Xerostomia Therapeutics Market, Global, Revenue ($m), 2006 - 2011 Table 4: Xerostomia Therapeutics Market, Global, Forecast ($m), 2011 - 2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Table 5: Xerostomia Therapeutics Market, The US, Revenue ($m), 2006 - 2011 Table 6: Xerostomia Therapeutics Market, The US, Forecast ($m), 2011 - 2019 Table 7: Xerostomia Therapeutics Market, The UK, Revenue ($m), 2006 - 2011 Table 8: Xerostomia Therapeutics Market, The UK, Forecast ($m), 2011 - 2019 Table 9: Xerostomia Therapeutics Market, France, Revenue ($m), 2006 - 2011 Table 10: Xerostomia Therapeutics Market, France, Forecast ($m), 2011 - 2019 Table 11: Xerostomia Therapeutics Market, Germany, Revenue ($m), 2006 - 2011 Table 12: Xerostomia Therapeutics Market, Germany, Forecast ($m), 2011 - 2019 Table 13: Xerostomia Therapeutics Market, Italy, Revenue ($m), 2006 - 2011 Table 14: Xerostomia Therapeutics Market, Italy, Forecast ($m), 2011 - 2019 Table 15: Xerostomia Therapeutics Market, Spain, Revenue ($m), 2006 - 2011 Table 16: Xerostomia Therapeutics Market, Spain, Forecast ($m), 2011 - 2019 Table 17: Xerostomia Therapeutics Market, Japan, Revenue ($m), 2006 - 2011 Table 18: Xerostomia Therapeutics Market, Japan, Forecast ($m), 2011 - 2019 Table 19: Xerostomia Disease Therapeutics Product Profiles, Incidence of Grade 2 or Higher Xerostomia Table 20: Xerostomia Therapeutics, Phase II Pipeline, 2011 Table 21: Xerostomia Therapeutics, Clinical Trials by Country, 2011 Table 22: Xerostomia Therapeutics, Clinical Trials by Phase, 2011 Table 23: Xerostomia Therapeutics, Clinical Trials by Status, 2011 Table 24: Xerostomia Therapeutics, Prominent Sponsors, 2011 Table 25: Xerostomia Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2011 Table 26: Parion Sciences - Sjogren’s Syndrome (Associated with Xerostomia) Therapeutics Pipeline, 2011 Table 27: Acacia Pharma Pipeline for Xerosomia Therapeutics, 2011 Table 28: Marillion Pharmaceuticals, Pipeline for Xerostomia Therapeutics, 2011 Table 29: Xerostomia Therapeutics, Global, Deals, 2009-2011
List Of Figures Figure 1: Examples of Drugs That Cause Xerostomia Figure 2: Xerostomia Therapeutics Market, Global, Revenue ($m), 2006 - 2011 Figure 3: Xerostomia Therapeutics Market, Global, Forecast ($m), 2011 - 2019 Figure 4: Xerostomia Therapeutics Market, The US, Revenue ($m), 2006 - 2011 Figure 5: Xerostomia Therapeutics Market, The US, Forecast ($m), 2011 - 2019 Figure 6: Xerostomia Therapeutics Market, The UK, Revenue ($m), 2006 - 2011 Figure 7: Xerostomia Therapeutics Market, The UK, Forecast ($m), 2011 - 2019 Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Figure 8: Xerostomia Therapeutics Market, France, Revenue ($m), 2006 - 2011 Figure 9: Xerostomia Therapeutics Market, France, Forecast ($m), 2011 - 2019 Figure 10: Xerostomia Therapeutics Market, Germany, Revenue ($m), 2006 - 2011 Figure 11: Xerostomia Therapeutics Market, Germany, Forecast ($m), 2011 - 2019 Figure 12: Xerostomia Therapeutics Market, Italy, Revenue ($m), 2006 - 2011 Figure 13: Xerostomia Therapeutics Market, Italy, Forecast ($m), 2011 - 2019 Figure 14: Xerostomia Therapeutics Market, Spain, Revenue ($m), 2006 - 2011 Figure 15: Xerostomia Therapeutics Market, Spain, Forecast ($m), 2011 - 2019 Figure 16: Xerostomia Therapeutics Market, Japan, Revenue ($m), 2006 - 2011 Figure 17: Xerostomia Therapeutics Market, Japan, Forecast ($m), 2011 - 2019 Figure 18: Opportunity and Unmet Need in the Sjogren’s Syndrome Patients Experiencing Xerostomia Figure 19: Opportunity and Unmet Need in the Xerostomia Patients Derived from the Head and Neck Cancer Patients Pool Figure 20: Strategic Competitor Assessment of the Major Marketed Products in Xerostomia, 2011 Figure 21: Xerostomia Therapeutics - Pipeline by Phase of Development, 2011 Figure 22: Xerostomia Therapeutics, Technology Trends Analytics Framework, 2011 Figure 23: Xerostomia Therapeutics, Technology Trends Analytics Framework, Description, 2011 Figure 24: Xerostomia Therapeutics, Pipeline by Mechanism of Action, 2011 Figure 25: Xerostomia Therapeutics, Clinical Trials by Country, 2011 Figure 26: Xerostomia Therapeutics, Clinical Trials by Phase (%), 2011 Figure 27: Xerostomia Therapeutics, Clinical Trials by Status, 2011 Figure 28: Xerostomia Therapeutics, Overall Sponsors (%), 2011 Figure 29: Xerostomia Therapeutics, Prominent Sponsors (%), 2011 Figure 30: Xerostomia Therapeutics - Top Companies Participating in Therapeutics Clinical Trials, 2011 Figure 31: Xerostomia Therapeutics Market, Drivers and Barriers, 2011 Figure 32: Implications for Future Market Competition in the Xerostomia Market, 2011 Figure 33: Xerostomia Therapeutics, Clinical Pipeline by Company, 2011
Report Price: Licence Type
Price
$ 3995
Site Licence
$ 7990
Enterprise Wide Licence
$ 11985
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/
Related Reports: Sarcoidosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Pompe Disease (GAA Deficiency) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Cushings Syndrome Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Narcolepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Myelofibrosis Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Hereditary Angioedema Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Childhood Epilepsy Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Obsessive Compulsive Disorder (OCD) Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Traumatic Brain Injury Therapeutics - Pipeline Assessment and Market Forecasts to 2019 Osteoarthritis (OA) Pain Therapeutics - Pipeline Assessment and Market Forecasts to 2019
You can order this report by calling on +91 - 998 7295 242 or mail us your contact details at contact@jsbmarketresearch.com About JSB Market Research:JSB market research is a leading player in the market of research report distribution. It is onestop-shop for all information related to market research for any sector of the industry. Along with providing in-depth analysis though reports, JSB market research also provides regular updates of the market though newsletters. Our reports are a well-researched work of market researchers with an extensive knowledge and a good level of market experience.
To know more on Xerostomia Therapeutics - Pipeline Assessment and Market Forecasts to 2019 http://www.jsbmarketresearch.com/healthcare-medical/r-xerostomiatherapeutics-pipeline-assessment-and-market-forecasts-135246
Email ID- contact@jsbmarketresearch.com Tel No- 91 2241236650 Published by- http:/www.jsbmarketresearch.com/